Erythropoietin in the pathogenesis of anemia in multiple myeloma patients;Erytropoetyna w patogenezie niedokrwistości u chorych na szpiczaka mnogiego

Polskie Archiwum Medycyny Wewnetrznej

Volumn 99, Issue 3, 1998, Pages 218-223

  Rokicka Piotrowicz, Małgorzata ^a   Paluszewska, Monika ^a   Paszkowska, Małgorzata ^a   Rakowska, Agnieszka ^a   Wierzbicka, Elzbieta ^a   Buras, Anna ^a   Kuratowska, Zofia ^a  

^a Klin Chorob Wewnetrznych/R W   (Poland)

Author keywords

Anemia; Erythropoietin; Multiple myeloma

Indexed keywords

ERYTHROPOIETIN; FERRITIN; IRON;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD; BLOOD CELL COUNT; BONE MARROW; CD8+ T LYMPHOCYTE; CLINICAL TRIAL; CYTOLOGY; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEEDLE BIOPSY; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; BIOPSY, NEEDLE; BLOOD CELL COUNT; BONE MARROW; CD8-POSITIVE T-LYMPHOCYTES; ERYTHROPOIETIN; FEMALE; FERRITINS; HUMANS; IRON; MALE; MIDDLE AGED; MULTIPLE MYELOMA;

EID: 2442655525     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Barlogie B., Beck T.: Recombinant human erythropoietin and the anemia of multiple myeloma. Stem Cells, 1993, 11, 88.
2. Garton J.P., Gertz M.A., Witzig T.E. i wsp.: Erytropoietin alfa for treatment of the anemia of multiple myeloma. A prospective, randomized, placebo-controlled, duble-blind trial. Arch. Intern. Med., 1995, 155, 2069.
3. Osterborg A., Bogaerts M. A., Cimino R. i wsp.: Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non Hodgkin's lymphoma randomized multicenter study. The European Study Group of Erythropoietin (Epoietin Beta) treatment in multiple myeloma and non-Hodgkin's lymphoma. Blood, 1966, 87, 2675.
4. Robak T.: Leczenie szpiczaka mnogiego - stan obecny i perspektywy. Acta Haematol. PoL, 1996, 27, 5.
5. Beguin Y., Yerna , Loo M. i wsp.: Erythropoiesis in multiple myeloma: defective red cell production due to inappropiate erythropoietin production. Br. J. Haematol., 1992, 82, 648.
6. Robak T.: Erytropoetyna w leczeniu niedokrwistości u chorych z nowotworami układu krwiotwórczego. Acta Haematol. Pol., 1996, 27, 213.
7. Durie B.G.M.: Staging and kinetics of multiple myeloma. Sem. Oncol., 1986, 13, 300.
8. Durie B.C.M., Salmon S. E.: The clinical staging system for multiple myeloma. Correlation of measured myeloma cells mass with presenting clinical features response to treatment and survival. Cancer. 1975, 36, 842.
9. McLeod D.L., Shreeve M.M., Axelard A.: Improoved plasma culture system for production of erythrocytic colonies in vitro: Quantitative assay method for CFE-E. Blood, 1974, 44, 517.
10. Ariad S., Clifford D., Penfold G. i wsp.; Erythropoietin response in anemic patients with multiple myeloma and other malignances infiltrating the bone marrow. Eur. J. Haematol., 1992, 49, 59.
11. Beguin Y.: Erythropoietin and anemia of cancer. Acta Clin. Belg., 1996, 51, 36.
12. Aoki I., Nishijma K., Homori M. i wsp.: Responsivenes of bone marrow erythroid progenitors (CFU-E and BFU-E) to recombinant human erythropoietin (rh-Ep) in vitro in multiple myeloma. Br. J. Haematol., 1992, 81, 463.
13. Rokicka-Piotrowiez M., Paszkowska M., Kuratowska Z.: Niedokrwistość a ste+ (combining ogonek sign)żenie erytropoetyny w niektórych chorobach nowotworowych ukiadu krwiotwórczego. Pol. Arch. Med. Wewn., 1994, 92, 409.
14. Means R.T. Jr, Kranz S.B.: Progress in understanding the pathogenesis of the anemia of chronic disease. Blood, 80, 1639.
15. Podolak-Dawidziak M.: Niedokrwistość w chorobach nowotworowych. Acta Haematol. Pol., 1996, 27, 379.
16. Beguin Y.: Erythropoiesis and erythropoietin in multiple myeloma (Review). Leukemia and Lymphoma, 1995, 18, 413.